SMARCB1 and neoplasm: From a molecular genetic perspective, nearly all cases exhibit biallelic inactivation (deletion or mutation) of the INI1 (hSNF5, SMARCB1) gene located on chromosome 22q11.2, and this loss of function is considered the primary driver of tumor development.